Biotech | June 19, 2023
Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Construction will begin this year with the new capacity anticipated by 2025
The Awards recognizes standout digital health & medical technology products and companies
Pheezee is designed to assess musculoskeletal and neuromuscular health.
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Getinge has a strong market share in India within several product segments
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Subscribe To Our Newsletter & Stay Updated
